Active Ingredient History

  • Now
Bromhexine is a mucolytic drug used in the treatment of respiratory disorders associated with viscid or excessive mucus. It was developed in the research laboratory of Boehringer Ingelheim in the late 1950s as an active ingredient for pharmaceutical use, patented in 1961, introduced in 1963 under the trademark of Bisolvon® and came into medical use in 1966.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
3,5-dibromo-n(alpha)-cyclohexyl-n(alpha)-methyltoluene-alpha-2-diamine | bisolvon | brombenzonium | bromexina | bromexine | bromhexina | bromhexine | bromhexine hcl | bromhexine hydrochloride | bromhexine monohydrochloride | bromhexinum | bromihexine hydrochloride | fluibron | na-274 | n-cyclohexyl-n-methyl-(2-amino-3,5-dibrombenzyl)amine | tauglicolo


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue